Pritsana Raungrut
15 Karnjanavanich Road
Hat Yai, 90110, Thailand
Hat Yai, 90110, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines.
Journal: International journal of molecular sciences
Published: February 11, 2026
Tiliacorinine as a Promising Candidate for Cholangiocarcinoma Therapy via Oxidative Stress Molecule Modulation: A Study Integrating Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation.
Journal: Antioxidants (Basel, Switzerland)
Published: August 29, 2025
Proteomic Profiling Reveals TPR and FGA as Predictive Serum Biomarkers of Relapse to First- and Second-Generation EGFR-TKIs in Advanced Lung Adenocarcinoma.
Journal: Biomedicines
Published: June 01, 2025
Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses.
Journal: International journal of molecular sciences
Published: December 09, 2024
Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens.
Journal: Current issues in molecular biology
Published: November 21, 2024
Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced Non‑Small Cell Lung Cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 02, 2023
Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: January 25, 2021
Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.
Journal: PloS one
Published: March 12, 2020
Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
Journal: Cancer biology & medicine
Published: February 12, 2020
Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
Journal: Anticancer research
Published: April 12, 2018
MicroRNA Isolation by Trizol-Based Method and Its Stability in Stored Serum and cDNA Derivatives.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: March 24, 2018
Last Updated: 09/26/2026